{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T17:56:58Z","timestamp":1772387818046,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T00:00:00Z","timestamp":1391472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00787-014-0523-1","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T13:53:47Z","timestamp":1391435627000},"page":"1211-1218","source":"Crossref","is-referenced-by-count":25,"title":["Use of SSRIs among Danish children: a nationwide study"],"prefix":"10.1007","volume":"23","author":[{"given":"Anton","family":"Potteg\u00e5rd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Zo\u00ebga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Hallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Damkier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"523_CR1","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/appi.ajp.2007.07030454","volume":"164","author":"RD Gibbons","year":"2007","unstructured":"Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA et al (2007) Early evidence on the effects of regulators\u2019 suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 164:1356\u20131363","journal-title":"Am J Psychiatry"},{"key":"523_CR2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMp038248","volume":"350","author":"B Vitiello","year":"2004","unstructured":"Vitiello B, Swedo S (2004) Antidepressant medications in children. N Engl J Med 350:1489\u20131491","journal-title":"N Engl J Med"},{"key":"523_CR3","unstructured":"The Danish Ministry of Health and Prevention. (Guide to medicamental treatment of children and adolescents with psychiatric disorders, VEJ no 10332); Cited 11 Dec 2012. Available from www.retsinformation.dk\/"},{"key":"523_CR4","unstructured":"European Medicines Agency (EMA). European Medicines Agency finalizes review of antidepressants in children and adolescents. EMEA\/CHMP\/128918\/2005; Cited 11 Dec 2012. Available from: www.ema.europa.eu"},{"key":"523_CR5","unstructured":"Summary of Product Characteristics.; Cited 11 Dec 2012. Available from: www.produktresume.dk"},{"key":"523_CR6","unstructured":"Danish Medicines Agency. (Drugs against depression for children and adolescents); Cited 11\/12\/2012. Available from: www.laegemiddelstyrelsen.dk"},{"key":"523_CR7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","volume":"287","author":"L Frank","year":"2000","unstructured":"Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398\u20132399","journal-title":"Science"},{"key":"523_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, Sorensen HT, Hallas J (2011) The Danish national prescription registry. Scand J Public Health 39:38\u201341","journal-title":"Scand J Public Health"},{"key":"523_CR9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1403494811409654","volume":"39","author":"LC Thygesen","year":"2011","unstructured":"Thygesen LC, Ersboll AK (2011) Danish population-based registers for public health and health-related welfare research: introduction to the supplement. Scand J Public Health 39:8\u201310","journal-title":"Scand J Public Health"},{"key":"523_CR10","unstructured":"National Institute for Health Data and Disease Control. Medstat.dk; Cited 4 April 2013. Available from: www.medstat.dk\/en"},{"key":"523_CR11","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. 2012 Oslo"},{"key":"523_CR12","unstructured":"European Medicines Agency (EMA). ICH Topic E 11: Clinical Investigation of Medicinal Products in the Paediatric Population. Note for guidance on clinical investigation of medicinal products in the paediatric population (CPMP\/ICH\/2711\/99). 2001"},{"key":"523_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/08039480801984065","volume":"62","author":"JB Nissen","year":"2008","unstructured":"Nissen JB, Thomsen PH (2008) Clinicians\u2019 views on clinical examination and treatment of children and adolescents with obsessive-compulsive disorder (OCD). A Danish national survey study. Nord J Psychiatry 62:309\u2013314","journal-title":"Nord J Psychiatry"},{"key":"523_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/cap.2007.0049","volume":"18","author":"SK Bhatia","year":"2008","unstructured":"Bhatia SK, Rezac AJ, Vitiello B, Sitorius MA, Buehler BA, Kratochvil CJ (2008) Antidepressant prescribing practices for the treatment of children and adolescents. J Child Adolesc Psychopharmacol 18:70\u201380","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1503\/cmaj.071265","volume":"178","author":"LY Katz","year":"2008","unstructured":"Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J (2008) Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ 178:1005\u20131011","journal-title":"CMAJ"},{"key":"523_CR16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/pds.1886","volume":"19","author":"CA Pamer","year":"2010","unstructured":"Pamer CA, Hammad TA, Wu YT, Kaplan S, Rochester G, Governale L et al (2010) Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiol Drug Saf 19:158\u2013174","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"523_CR17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/MLR.0b013e3181ef9d2b","volume":"48","author":"S Valluri","year":"2010","unstructured":"Valluri S, Zito JM, Safer DJ, Zuckerman IH, Mullins CD, Korelitz JJ (2010) Impact of the 2004 food and drug administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression. Med Care 48:947\u2013954","journal-title":"Med Care"},{"key":"523_CR18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/adc.2004.064956","volume":"89","author":"ML Murray","year":"2004","unstructured":"Murray ML, de Vries CS, Wong IC (2004) A drug utilisation study of antidepressants in children and adolescents using the general practice research database. Arch Dis Child 89:1098\u20131102","journal-title":"Arch Dis Child"},{"key":"523_CR19","doi-asserted-by":"crossref","first-page":"e33181","DOI":"10.1371\/journal.pone.0033181","volume":"7","author":"LP Wijlaars","year":"2012","unstructured":"Wijlaars LP, Nazareth I, Petersen I (2012) Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). PLoS One 7:e33181","journal-title":"PLoS One"},{"key":"523_CR20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/cap.2009.0003","volume":"19","author":"H Zoega","year":"2009","unstructured":"Zoega H, Baldursson G, Hrafnkelsson B, Almarsdottir AB, Valdimarsdottir U, Halldorsson M (2009) Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol 19:757\u2013764","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00228-012-1233-6","volume":"68","author":"LK Saastamoinen","year":"2012","unstructured":"Saastamoinen LK, Wallin M, Lavikainen P, Airaksinen MS, Sourander A, Bell JS (2012) Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study. Eur J Clin Pharmacol 68:1109\u20131117","journal-title":"Eur J Clin Pharmacol"},{"key":"523_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/CLEP.S31624","volume":"4","author":"AK Steffenak","year":"2012","unstructured":"Steffenak AK, Wilde-Larsson B, Nordstrom G, Skurtveit S, Hartz I (2012) Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. Clin Epidemiol 4:225\u2013231","journal-title":"Clin Epidemiol"},{"key":"523_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/cap.2006.16.197","volume":"16","author":"JM Fegert","year":"2006","unstructured":"Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K (2006) Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197\u2013206","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/cap.2009.0018","volume":"19","author":"M Koelch","year":"2009","unstructured":"Koelch M, Prestel A, Singer H, Keller F, Fegert JM, Schlack R et al (2009) Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns. J Child Adolesc Psychopharmacol 19:765\u2013770","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/cap.2007.0091","volume":"18","author":"C Sevilla-Dedieu","year":"2008","unstructured":"Sevilla-Dedieu C, Kovess-Masfety V (2008) Psychotropic medication use in children and adolescents: a study from France. J Child Adolesc Psychopharmacol 18:281\u2013289","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamapediatrics.2013.431","volume":"167","author":"KR Merikangas","year":"2013","unstructured":"Merikangas KR, He JP, Rapoport J, Vitiello B, Olfson M (2013) Medication use in US youth with mental disorders. JAMA Pediatr 167:141\u2013148","journal-title":"JAMA Pediatr"},{"key":"523_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.chi.0000192249.61271.81","volume":"45","author":"B Vitiello","year":"2006","unstructured":"Vitiello B, Zuvekas SH, Norquist GS (2006) National estimates of antidepressant medication use among US children, 1997\u20132002. J Am Acad Child Adolesc Psychiatry 45:271\u2013279","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"523_CR28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/pds.1254","volume":"15","author":"JM Zito","year":"2006","unstructured":"Zito JM, Tobi H, de Jong-van den Berg LT, Fegert JM, Safer DJ, Janhsen K et al (2006) Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiol Drug Saf 15:793\u2013798","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"523_CR29","unstructured":"The Danish BupBase. (The Danish Database for Child and Adolescent Psychiatry 2005\u20132010 Annual Reports); Cited 5 March 2013. Available from: www.bupnet.dk"},{"key":"523_CR30","unstructured":"The Danish Health and Medicines Authority. (Development in Child and Adolescent Psychiatry Activity 2007\u20132010); Cited 12 March 2013. Available from: www.sst.dk"},{"key":"523_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/pds.2145","volume":"21","author":"E Lee","year":"2012","unstructured":"Lee E, Teschemaker AR, Johann-Liang R, Bazemore G, Yoon M, Shim KS et al (2012) Off-label prescribing patterns of antidepressants in children and adolescents. Pharmacoepidemiol Drug Saf 21:137\u2013144","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"523_CR32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00228-012-1344-0","volume":"69","author":"A Pottegard","year":"2013","unstructured":"Pottegard A, Bjerregaard BK, Glintborg D, Kortegaard LS, Hallas J, Moreno SI (2013) The use of medication against attention deficit\/hyperactivity disorder in Denmark: a drug use study from a patient perspective. Eur J Clin Pharmacol 69:589\u2013598","journal-title":"Eur J Clin Pharmacol"},{"key":"523_CR33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00228-012-1265-y","volume":"68","author":"A Pottegard","year":"2012","unstructured":"Pottegard A, Bjerregaard BK, Glintborg D, Hallas J, Moreno SI (2012) The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective. Eur J Clin Pharmacol 68:1443\u20131450","journal-title":"Eur J Clin Pharmacol"},{"key":"523_CR34","doi-asserted-by":"crossref","unstructured":"Diaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C (2012) Polypharmacy with antidepressants in children and adolescents. Int J Neuropsychopharmacol 1\u201320 [Epub ahead of print]","DOI":"10.1017\/S1461145712001265"},{"key":"523_CR35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaac.2010.07.007","volume":"49","author":"JS Comer","year":"2010","unstructured":"Comer JS, Olfson M, Mojtabai R (2010) National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996\u20132007. J Am Acad Child Adolesc Psychiatry 49:1001\u20131010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"523_CR36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/cap.2006.16.273","volume":"16","author":"AJ Dean","year":"2006","unstructured":"Dean AJ, McDermott BM, Marshall RT (2006) Psychotropic medication utilization in a child and adolescent mental health service. J Child Adolesc Psychopharmacol 16:273\u2013285","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4088\/JCP.08m04212","volume":"70","author":"RS McIntyre","year":"2009","unstructured":"McIntyre RS, Jerrell JM (2009) Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study. J Clin Psychiatry 70:240\u2013246","journal-title":"J Clin Psychiatry"},{"key":"523_CR38","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1542\/peds.108.2.e25","volume":"108","author":"E Schirm","year":"2001","unstructured":"Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT (2001) Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25","journal-title":"Pediatrics"},{"key":"523_CR39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1399-5618.2010.00791.x","volume":"12","author":"B Geller","year":"2010","unstructured":"Geller B, Tillman R, Bolhofner K, Zimerman B (2010) Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord 12:164\u2013171","journal-title":"Bipolar Disord"},{"key":"523_CR40","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.64.9.1032","volume":"64","author":"C Moreno","year":"2007","unstructured":"Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M (2007) National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 64:1032\u20131039","journal-title":"Arch Gen Psychiatry"},{"key":"523_CR41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/cap.2005.15.12","volume":"15","author":"FF Duffy","year":"2005","unstructured":"Duffy FF, Narrow WE, Rae DS, West JC, Zarin DA, Rubio-Stipec M et al (2005) Concomitant pharmacotherapy among youths treated in routine psychiatric practice. J Child Adolesc Psychopharmacol 15:12\u201325","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/cap.2005.15.26","volume":"15","author":"EM Hunkeler","year":"2005","unstructured":"Hunkeler EM, Fireman B, Lee J, Diamond R, Hamilton J, He CX et al (2005) Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994\u20132003. J Child Adolesc Psychopharmacol 15:26\u201337","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/cap.2008.032","volume":"18","author":"WB Daviss","year":"2008","unstructured":"Daviss WB (2008) A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. J Child Adolesc Psychopharmacol 18:565\u2013571","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"523_CR44","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.janxdis.2010.06.009","volume":"24","author":"BH Esbjorn","year":"2010","unstructured":"Esbjorn BH, Hoeyer M, Dyrborg J, Leth I, Kendall PC (2010) Prevalence and co-morbidity among anxiety disorders in a national cohort of psychiatrically referred children and adolescents. J Anxiety Disord 24:866\u2013872","journal-title":"J Anxiety Disord"},{"key":"523_CR45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.8.5.555","volume":"8","author":"A Kunwar","year":"2007","unstructured":"Kunwar A, Dewan M, Faraone SV (2007) Treating common psychiatric disorders associated with attention-deficit\/hyperactivity disorder. Expert Opin Pharmacother 8:555\u2013562","journal-title":"Expert Opin Pharmacother"},{"key":"523_CR46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-5618.2006.00342.x","volume":"8","author":"G Masi","year":"2006","unstructured":"Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N et al (2006) Attention-deficit hyperactivity disorder: bipolar comorbidity in children and adolescents. Bipolar Disord 8:373\u2013381","journal-title":"Bipolar Disord"},{"key":"523_CR47","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1345\/aph.1Q020","volume":"45","author":"CA Fontanella","year":"2011","unstructured":"Fontanella CA, Bridge JA, Marcus SC, Campo JV (2011) Factors associated with antidepressant adherence for Medicaid-enrolled children and adolescents. Ann Pharmacother 45:898\u2013909","journal-title":"Ann Pharmacother"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-014-0523-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-014-0523-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-014-0523-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T08:14:08Z","timestamp":1565165648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-014-0523-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1007\/s00787-014-0523-1","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,4]]}}}